These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18209438)

  • 1. Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2003; 14(2):134-44. PubMed ID: 18209438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitude of Physicians toward the Use of Erythropoietin in Hemodialysis Patients.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2005; 16(3):298-305. PubMed ID: 17642796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients.
    Shaheen FA; Souqiyyeh MZ; Akeel N
    Saudi J Kidney Dis Transpl; 2002; 13(2):131-40. PubMed ID: 17660651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitude of physicians in saudi arabia towards heparin administration and monitoring in hemodialysis patients.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2003; 14(4):475-80. PubMed ID: 17657119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of the attitude of physicians towards establishing and maintaining a peritoneal dialysis program.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):355-64. PubMed ID: 16970256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitude of physicians towards the follow-up of renal transplant patients: a questionnaire survey in Saudi Arabia.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):159-67. PubMed ID: 16903621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The attitude of physicians towards education and rehabilitation of patients on chronic dialysis: a questionnaire survey.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):526-34. PubMed ID: 17186688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Iron Saccharate in Hemodialysis Patients Receiving r-HuEPO.
    Al-Momen AK; Huraib SO; Mitwalli AH; Al-Wakeel J; Al-Yamani MJ; Abu-Aisha H; Said R
    Saudi J Kidney Dis Transpl; 1994; 5(2):168-72. PubMed ID: 18583828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and iron.
    Sunder-Plassmann G; Hörl WH
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S; Lynn RI
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.